跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SII-Onco-BCG - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
SII-Onco-BCG
Approved
STANDARD
SII-Onco-BCG
Serum Institute of India Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
fd32cc18da784d65
Company
Serum Institute of India Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
fd32cc18da784d65
Drug Approval Philippines Name
SII-Onco-BCG
Product Name
SII-Onco-BCG
Registration Number
BR-851
Brand Name
SII-Onco-BCG
Generic Name
Bacillus Calmette-Guerin Vaccine (Live, Attenuated)
Dosage Form
Lyophilized Powder for Intravesical Instillation
Dosage Strength
40 mg/mL
Manufacturer
Serum Institute of India Pvt. Ltd.
Importer
SMHP Marketing & Consultancy
Distributor
SMHP Marketing & Consultancy
Company Detail Path
/organization/serum-institute-of-india-pvt-ltd
Issuance Date
18 December 2023
Expiry Date
18 December 2028
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
fd32cc18da784d65
Type
Standard
Back to Philippines FDA Approvals